520 Chapter | 16 Kidney Function and Damage Jensen , A. L. , Bomholt , M. , and Moe , L. ( 2001 ). Preliminary evaluation <strong>of</strong> a particle-enhanced turbidimetric immunoassay (PETIA) for the determination <strong>of</strong> serum cystatin C-like immunoreactivity in dogs . Vet. Clin. Pathol. 30 , 86 – 90 . Jensen , A. L. , Wenck , A. , Koch , J. , and Poulsen , J. S. D. ( 1994 ). Comparison <strong>of</strong> results <strong>of</strong> haematological and clinical chemical analyses <strong>of</strong> blood samples obtained from the cephalic and external jugular veins in dogs . Res. Vet. Sci. 56 , 24 – 29 . Jeraj , K. P. , Vernier , R. L. , Polzin , D. , Klausner , J. K. , Osborne , C. A. , Stevens , J. B. , and Michael , A. F. ( 1984 ). Idiopathic immune complex glomerulonephritis in dogs with multisystem involvement . Am. J. Vet. Res. 45 , 1699 – 1705 . Jergens , A. E. , McCaw , D. L. , and Hewett , J. E. ( 1987 ). Effects <strong>of</strong> collection time and food consumption on the urine protein/creatinine ratio in the dog . Am. J. Vet. Res. 48 , 1106 – 1109 . Joles, J. A., Rijnberk, A., Brom, v. d., and W. E., D., J. (1980). Studies on the mechanism <strong>of</strong> polyuria induced by cortisol excess in the dog. Vet. Quarterly 2 , 199–205. Jolliffe , N. , and Smith , H. W. (1932 ). The excretion <strong>of</strong> urine in the dog. II. The urea and creatinine clearance on cracker meal diet . Am. J. Physiol. 99 , 101 – 107 . Jones , G. R. D. , Strugnell , S. A. , and DeLuca , H. F. ( 1998 ). Current understanding <strong>of</strong> the molecular action <strong>of</strong> vitamin D . Physiol. Rev. 78 , 1193 – 1231 . Jones , J. D. , and Burnett , P. C. ( 1972 ). Implication <strong>of</strong> creatinine and gut flora in the uremic syndrome: induction <strong>of</strong> “ creatininase ” in colon contents <strong>of</strong> the rat by dietary creatinine . Clin. Chem. 18 , 280 – 284 . Jones , J. D. , and Burnett , P. C. ( 1974 ). Creatinine metabolism in humans with decreased renal function: creatinine deficit . Clin. Chem. 20 , 1204 – 1212 . Jung , K. , Mattenheimer , H. , and Burchardt , U. ( 1992 ). “ Urinary Enzymes in <strong>Clinical</strong> and Experimental Medicine . ” Springer Verlag , Berlin . Jung , K. , Wesslau , C. , Priem , F. , Schreiber , G. , and Zubek , A. ( 1987 ). Specific creatinine determination in laboratory animals using the new enzymatic test kit “ creatinine-PAP . ” J. Clin. Chem. Clin. Biochem. 25 , 357 – 361 . Kampa , N. , Bostrom , I. , Lord , P. , Wennstrom , U. , Ohagen , P. , and Maripuu , E. ( 2003 ). Day-to-day variability in glomerular filtration rate in normal dogs by scintigraphic technique . J. Vet. Med. A. Physiol. Pathol. Clin. Med. 50 , 37 – 41 . Kampa , N. , Wennstrom , U. , Lord , P. , Twardock , R. , Maripuu , E. , Eksell , P. , and Fredriksson , S. O. (2002 ). Effect <strong>of</strong> region <strong>of</strong> interest selection and uptake measurement on glomerular filtration rate measured by 99mTc-DTPA scintigraphy in dogs . Vet. Radiol. Ultrasound 43 , 383 –391 . Kaneko , J. J. , Mattheeuws , D. , Rottiers , R. P. , and Vermeulen , A. ( 1978 ). Renal function, insulin secretion, and glucose tolerance in mild streptozotocin diabetes in the dog . Am. J. Vet. Res. 39 , 807 – 809 . Kaneko , J. J. , Mattheeuws , D. , Rottiers , R. P. , and Vermuelen , A. ( 1979 ). Renal clearance, insulin secretion and glucose tolerance in spontaneous diabetes mellitus <strong>of</strong> dogs . Cornell. Vet. 69 , 375 – 383 . Kasari , T. R. , Woodbury , A. H. , and Morcom-Kasari , E. ( 1990 ). Adverse effect <strong>of</strong> orally administered magnesium hydroxide on serum magnesium concentration and systemic acid-base balance in adult cattle . J. Am. Vet. Med. Assoc. 196 , 735 – 742 . Keller , P. , and Freudiger , U. ( 1984 ). Enzymaktivitäten im Urin, im Liquor cerebrospinalis, in der Blasengalle, im Speichel und im Ejakulat des Hundes . Kleintier. Praxis 29 , 15 – 34 . Kennedy , T. J. , Hilton , J. G. , and Berliner , R. W. ( 1952 ). Comparison <strong>of</strong> inulin and creatinin clearance in the normal dog . Am. J. Physiol. 171 , 164 – 168 . Kerr , W. S. ( 1958 ). Maximum clearances (GFR and ERPF) in dogs . J. Urol . 80 , 205 – 207 . King , C. ( 1994 ). Practical use <strong>of</strong> urinary fractional excretion . J. Eq. Vet. Med. 14 , 464 – 468 . Kitagawa , H. , Wakamiya , H. , Kitoh , K. , Kuwahara , Y. , Ohba , Y. , Isaji , M. , Iwasaki , T. , Nakano , M. , and Sasaki , H. ( 1997 ). Efficacy <strong>of</strong> monotherapy with benazepril, an angiotensin converting enzyme inhibitor, in dogs with naturally acquired mitran insufficiency . J. Vet. Med. Sci. 59 , 513 – 520 . Klee , W. , Seitz , A. , and Elmer-Englhard , D. ( 1985 ). Untersuchungen über den Kreatinin- und harnst<strong>of</strong>f-Blutspiegel gesunder neugeborener Kälber im Hinblick auf deren Nierenfunktion . Dtsch. Tierärztl. Wochenschr. 92 , 405 – 407 . Kleinman , L. I. , and Lubbe , R. J. ( 1972 ). Factors affecting the maturation <strong>of</strong> glomerular filtration rate and renal plasma flow in the new-born dog . J. Physiol. 223 , 395 – 409 . Knudsen , E. ( 1959 ). Renal clearance studies in the horse. I. Inulin, endogeneous creatinine and urea . Acta. Vet. Scand. 1 , 52 – 6 6 . Ko , J. C. H. , Miyabiyashi , T. , Mandsager , R. A. , Heaton-Jones , T. G. , and Mauragis , D. F. ( 2000 ). Renal effects <strong>of</strong> carpr<strong>of</strong>en administered to healthy dogs anesthetized with prop<strong>of</strong>ol and is<strong>of</strong>lurane . J. Am. Vet. Med. Assoc. 217 , 346 – 349 . Kohn , R. A. , Dinneen , M. M. , and Russek-Cohen , E. ( 2005 ). Using blood urea nitrogen to predict nitrogen excretion and efficiency <strong>of</strong> nitrogen utilization in cattle, sheep, goats, horses, pigs, and rats . J. Anim. Sci. 83 , 879 – 889 . Kohn , C. W. , and Strasser , S. L. ( 1986 ). 24-hour renal clearance and excretion <strong>of</strong> endogenous substances in the mare . Am. J. Vet. Res. 47 , 1332 – 1337 . Kraft , W. , Hartmann , K. , and Dereser , R. ( 1996 ). Altersabhängigkeiten von Labowerten bei Hund und Katze. teil III: Bilirubin, Kreatinin und Protein im Blutserum . Tieräztl. Praxis 24 , 610 – 615 . Krawiec , D. R. , and Gelberg , H. B. (1989 ). Chronic renal disease in cats . In “Current Veterinary Therapy X Small Animal Practice ” (R. W. Kirk and J. D. Bonagura , Eds.) , pp. 1170 –1173 . Saunders , Philadelphia . Krawiec , D. R. , Twardock , A. R. , Badertscher , R. R. , 2nd , Daniel , G. B. , and Dugan , S. J. (1988 ). Use <strong>of</strong> 99mTc diethylenetriaminepentaacetic acid for assessment <strong>of</strong> renal function in dogs with suspected renal disease . J. Am. Vet. Med. Assoc. 192 , 1077 – 1180 . Kriz , W. , and Bankir , L. ( 1988 ). A standard nomenclature for structures <strong>of</strong> the kidney. The Renal Commission <strong>of</strong> the International Union <strong>of</strong> Physiological Sciences (IUPS) . Kidney Int. 33 , 1 – 7 . Krogh , P. , Elling , F. , Friis , C. , Hald , B. , Larsen , A. E. , Lillehoj , E. B. , Madsen , A. , Mortensen , H. P. , Rasmussen , F. , and Ravnskov , U. (1979 ). Porcine nephropathy induced by long-term ingestion <strong>of</strong> ochratoxin A . Vet. Pathol. 16 , 466 – 475 . Kronfeld , D. S. , Hammel , E. P. , Ramberg , C. F. , and Dunlap , H. L. ( 1977 ). Hematological and metabolic responses to training in racing sled dogs fed diets containing medium, low or zero carbohydrate . Am. J. Clin. Nutr. 30 , 419 – 430 . Kruger , J. M. , and Osborne , C. A. (1994a ). Canine and feline hypercalcemic nephropathy. Part I. Causes and consequences . Comp. Cont. Educ. Pract. Vet. 16 , 1299 – 1315 . Kruger , J. M. , and Osborne , C. A. (1994b ). Canine and feline hypercalcemic nephropathy. Part II. Detection, cure, and control . Comp. Cont. Educ. Pract. Vet. 16 , 1445 – 1459 . Kruger , J. M. , Osborne , C. A. , Nachreiner , R. F. , and Refsal , K. R. ( 1996 ). Hypercalcemia and renal failure. Etiology, pathophysiology, diagnosis, and treatment . Vet. Clin. North. Am. Small. Anim. Pract. 26 , 1417 – 1445 .
References 521 Kühl , S. , Mischke , R. , Lund , C. , and Günzel-Apel , A. R. ( 2000 ). Referenzwerte klinisch-chemischer Blutparameter bei Hundewelpen in den ersten acht Lebenswochen . Dtsch. Tieräztl. Wschr. 107 , 438 – 443 . Kuhn , G. , and Hardegg , W. ( 1988 ). Effects <strong>of</strong> indoor and outdoor maintenance <strong>of</strong> dogs upon food intake, body weight, and different blood parameters . Z. Versuchstierk 31 , 2005 – 2214 . Kumar , R. ( 1984 ). Metabolism <strong>of</strong> 1,25-dihydroxyvitamin D3 . Physiol. Rev. 64 , 487 – 504 . Kunkel , P. A. ( 1930 ). The number and size <strong>of</strong> the glomeruli in the kidney <strong>of</strong> several species . Bull. John. Hopkins. Hosp. 47 , 285 – 291 . Kunze , C. , Bahr , A. , and Lees , G. E. ( 2006 ). Evaluation <strong>of</strong> 99M TC-diethylenetriaminepentaacetic acid renal scintigram curves in normal dogs after induction <strong>of</strong> diuresis . Vet. Radiol. Ultrasound 47 , 103 – 107 . Kurtz , J. M. , Russell , S. W. , Lee , J. C. , Slauson , D. O. , and Schechter , R. D. ( 1972 ). Naturally occurring canine glomerulonephritis . Am. J. Pathol. 67 , 471 – 482 . Labato , M. A. , and Ross , L. A. ( 1991 ). Plasma disappearance <strong>of</strong> creatinine as a renal function test in the dog . Res. Vet. Sci. 50 , 253 – 258 . Ladd , M. , Liddle , L. , and Gagnon , J. A. ( 1956 ). Renal excretion <strong>of</strong> inulin, creatinine, and ferrocyanide, at normal and reduced clearance levels in the dog . Am. J. Physiol. 184 , 505 – 514 . Ladd , M. , Liddle , L. , Gagnon , J. A. , and Clarke , R. W. ( 1957 ). Glomerular and tubular functions in sheep and goats . J. Appl. Physiol. 10 , 249 – 255 . Lane , I. F. , Grauer , G. F. , and Fettman , M. J. ( 1994 a ). Acute renal failure. Risk factors, prevention, and strategies for protection . Comp. Cont. Educ. Pract. Vet. 16 , 15 – 29 . Lane , I. F. , Grauer , G. F. , and Fettman , M. J. ( 1994 b ). Acute renal failure. Part II. Diagnosis, management, and prognosis . Comp. Cont. Educ. Pract. Vet. 16 , 625 – 642 . Lane , I. F. , Shaw , D. H. , Burton , S. A. , and Donald , A. W. ( 2000 ). Quantitative urinalysis in healthy Beagle puppies from 9 to 27 weeks <strong>of</strong> age . Am. J. Vet. Res. 61 , 577 – 581 . Lane , V. M. , and Merritt , A. M. ( 1983 ). Reliability <strong>of</strong> single-sample phosphorus fractional excretion determination as a measure <strong>of</strong> daily phosphorus renal clearance in equids . Am. J. Vet. Res. 44 , 500 – 502 . Laroche , M. , and Boyer , J. F. ( 2005 ). Phosphate diabetes, tubular phosphate reabsorption and phosphatonins . Joint Bone Spine 72 , 376 – 381 . Laroute , V. , Chetboul , V. , Roche , L. , Maurey , C. , Costes , G. , Pouchelon , J. L. , De La Farge , F. , Boussouf , M. , and Lefebvre , H. P. (2005 ). Quantitative evaluation <strong>of</strong> renal function in healthy Beagle puppies and mature dogs . Res. Vet. Sci. 79 , 161 – 167 . Laterza , O. F. , Price , C. P. , and Scott , M. G. ( 2002 ). Cystatin C: an improved estimator <strong>of</strong> glomerular filtration rate Clin. Chem. 48 , 699 – 707 . Lee , K. E. , Behrendt , U. , Kaczmarczyk , G. , Mohnhaupt , R. , and Reinhardt , H. W. ( 1983 ). Estimation <strong>of</strong> glomerular filtration rate in concious dogs following a bolus <strong>of</strong> creatinine. Comparison with simultaneously determined inulin clearance . Pfl ugers Arch. 396 , 176 – 178 . Lees , G. E. ( 1996 ). Congenital renal diseases . Vet. Clin. North Am. Small Anim. Pract. 26 , 1379 – 1399 . Lees , G. E. , Brown , S. A. , Elliott , J. , Grauer , G. E. , and Vaden , S. L. ( 2005 ). Assessment and management <strong>of</strong> proteinuria in dogs and cats: 2004 ACVIM Forum Consensus Statement (small animal) . J. Vet. Intern. Med. 19 , 377 – 385 . Lees , G. E. , Helman , R. G. , Homco , L. D. , Millichamp , N. J. , Hunter , J. F. , and Frey , M. S. (1998 ). Early diagnosis <strong>of</strong> familial nephropathy in English cocker spaniels . J. Am. Anim. Hosp. Assoc. 34 , 189 – 195 . Lees , G. E. , and Osborne , C. A. ( 1979 ). Antibacterial properties <strong>of</strong> urine: a comparative review . J. Am. Anim. Hosp. Assn . 15 , 135–141 . Lefebvre , H. P. , Laroute , V. , Concordet , D. , and Toutain , P. L. ( 1999 ). Effects <strong>of</strong> renal impairment on the disposition <strong>of</strong> orally administered enalapril, benazepril, and their active metabolites . J. Vet. Intern. Med. 13 , 21 – 27 . Lefebvre , H. P. , Schneider , M. , Dupouy , V. , Laroute , V. , Costes , G. , Delesalle , L. , and Toutain , P. L. ( 1998 a ). Effect <strong>of</strong> experimental renal impairment on disposition <strong>of</strong> marb<strong>of</strong>loxacin and its metabolites in the dog . J. Vet. Pharmacol. Ther. 21 , 453 – 461 . Lefebvre , H. P. , Watson , A. D. J. , Toutain , P. L. , and Braun , J. P. (1998b ). Absence de validation technique et biologique de la créatininémie du chien: une des difficultés de l’interprétation . Revue. Med. Vet. 149 , 7 – 14 . Leifer , C. E. , and Matus , R. E. (1986 ). Chronic lymphocytic leukemia in the dog: 22 cases (1974–1984) . J. Am. Vet. Med. Assoc. 189 , 214 –217 . Lobetti , R. , and Lambrechts , N. ( 2000 ). Effects <strong>of</strong> general anesthesia and surgery on renal function in healthy dogs . Am. J. Vet. Res. 61 , 121 – 124 . Lobetti , R. G. , and Joubert , K. E. ( 2000 ). Effect <strong>of</strong> administration <strong>of</strong> nonsteroidal anti-inflammatory drugs before surgery on renal function in clinically normal dogs . Am. J. Vet. Res. 61 , 1501 – 1506 . Lobetti , R. G. , Reyers , F. , and Nesbit , J. W. ( 1996 ). The comparative role <strong>of</strong> haemoglobinaemia and hypoxia in the development <strong>of</strong> canine babesial nephropathy . J. S. Afr. Vet. Assoc. 67 , 188 – 198 . Lora-Michiels , M. , Anzola , K. , Amaya , G. , and Solano , M. ( 2001 ). Quantitative and qualitative scintigraphic measurement <strong>of</strong> renal function in dogs exposed to toxic doses <strong>of</strong> gentamicin . Vet. Radiol. Ultrasound 42 , 553 – 561 . Lording , P. M. , and Bellamy , J. E. C. ( 1978 ). Trimethoprim and sulfadiazin: adverse effects <strong>of</strong> long-term administration in dogs . J. Am. Anim. Hosp. Assoc. 14 , 410 – 417 . Lourens , D. C. , Dormehl , I. , and Goosen , D. J. ( 1982 ). The feasability <strong>of</strong> a renogram study in dogs with radiopharmaceutical 99mTc-DTPA . J. Sth. Afr. Vet. Assoc. 53 , 243 – 248 . Lowe , J. A. , Murphy , M. , and Nash , V. (1998 ). Changes in plasma and muscle creatine concentration after increases in supplementary dietary creatine in dogs . J. Nutr. 128 , 2691S – 2693S . Lowseth , L. A. , Gillett , N. A. , Gerlach , R. F. , and Muggenburg , B. A. ( 1990 ). The effects <strong>of</strong> aging on hematology and serum chemistry values in the beagle dog . Vet. Clin. Pathol. 19 , 13 – 19 . Lulich , J. P. , and Osborne , C. A. ( 1990 ). Interpretation <strong>of</strong> urine proteincreatinine ratios in dogs with glomerular and nonglomerular disorders . Comp. Cont. Educ. Pract. Vet. 12 , 59 – 73 . Lulich , J. P. , Osborne , C. A. , O’Brien , T. D. , and Polzin , D. J. ( 1992 ). Feline renal failure: questions, answers, questions . Comp. Cont. Educ. Pract. Vet. 14 , 127–152 . Lulich , J. P. , Osborne , C. A. , and Polzin , D. J. ( 1996 ). Diagnosis and long-term management <strong>of</strong> protein-losing glomerulonephropathy: a 5-year case-based approach . Vet. Clin. North Am. Small Anim. Pract. 26 , 1401 – 1416 . Lulich , J. P. , Osborne , C. A. , Polzin , D. J. , Johnston , S. D. , and Parker , M. L. ( 1991 ). Urine metabolite values in fed and nonfed clinically normal Beagles . Am. J. Vet. Res. 52 , 1573 – 1578 . Lund , E. M. , Armstrong , P. J. , Kirk , C. A. , Kolar , L. M. , and Klausner , J. S. ( 1999 ). Health status and population characteristics <strong>of</strong> dogs and cats examined at private veterinary practices in the United States . J. Am. Vet. Med. Assoc. 214 , 1336 – 1341 . Lunn , D. P. , and McGuirk , S. M. ( 1990 ). Renal regulation <strong>of</strong> electrolyte and acid-base balance in ruminants . Vet. Clin. N. Amer. Food. Anim. Pract. 6 , 1 – 28 .
- Page 1 and 2:
Preface It has been more than a dec
- Page 3 and 4:
viii Contributors Björn P. Meij (5
- Page 5 and 6:
2 Chapter | 1 Concepts of Normality
- Page 7 and 8:
4 Chapter | 1 Concepts of Normality
- Page 9 and 10:
6 Chapter | 1 Concepts of Normality
- Page 11 and 12:
8 Chapter | 1 Concepts of Normality
- Page 13 and 14:
10 Chapter | 1 Concepts of Normalit
- Page 15 and 16:
12 Chapter | 1 Concepts of Normalit
- Page 17 and 18:
14 Chapter | 1 Concepts of Normalit
- Page 19 and 20:
16 Chapter | 1 Concepts of Normalit
- Page 21 and 22:
18 Chapter | 1 Concepts of Normalit
- Page 23 and 24:
20 Chapter | 1 Concepts of Normalit
- Page 25 and 26:
22 Chapter | 1 Concepts of Normalit
- Page 27 and 28:
24 Chapter | 1 Concepts of Normalit
- Page 29 and 30:
Chapter 2 Comparative Medical Genet
- Page 31 and 32:
I. Introduction 29 Green Red Green
- Page 33 and 34:
I. Introduction 31 A1 genetic map d
- Page 35 and 36:
I. Introduction 33 of genomes of va
- Page 38 and 39:
36 Chapter | 2 Comparative Medical
- Page 40 and 41:
38 Chapter | 2 Comparative Medical
- Page 42 and 43:
40 Chapter | 2 Comparative Medical
- Page 44 and 45:
42 Chapter | 2 Comparative Medical
- Page 46 and 47:
44 Chapter | 2 Comparative Medical
- Page 48 and 49:
46 Chapter | 3 Carbohydrate Metabol
- Page 50 and 51:
48 Chapter | 3 Carbohydrate Metabol
- Page 52 and 53:
50 Chapter | 3 Carbohydrate Metabol
- Page 54 and 55:
52 Chapter | 3 Carbohydrate Metabol
- Page 56 and 57:
54 Chapter | 3 Carbohydrate Metabol
- Page 58 and 59:
56 Chapter | 3 Carbohydrate Metabol
- Page 60 and 61:
58 Chapter | 3 Carbohydrate Metabol
- Page 62 and 63:
60 Chapter | 3 Carbohydrate Metabol
- Page 64 and 65:
62 Chapter | 3 Carbohydrate Metabol
- Page 66 and 67:
64 Chapter | 3 Carbohydrate Metabol
- Page 68 and 69:
66 Chapter | 3 Carbohydrate Metabol
- Page 71 and 72:
IX. Disorders of Carbohydrate Metab
- Page 73 and 74:
IX. Disorders of Carbohydrate Metab
- Page 75 and 76:
IX. Disorders of Carbohydrate Metab
- Page 77 and 78:
X. Disorders of Ruminants Associate
- Page 79 and 80:
X. Disorders of Ruminants Associate
- Page 81 and 82:
References 79 Kaneko , J. J. , Luic
- Page 83 and 84:
Chapter 4 Lipids and Ketones Michae
- Page 85 and 86:
II. Long Chain Fatty Acids 83 FIGUR
- Page 87 and 88:
II. Long Chain Fatty Acids 85 Plasm
- Page 89 and 90:
IV. Phospholipids 87 The regulation
- Page 91 and 92:
V. Cholesterol 89 V. CHOLESTEROL A.
- Page 93 and 94:
VI. Lipoproteins 91 TABLE 4-1 Compo
- Page 95 and 96:
VI. Lipoproteins 93 TABLE 4-2 Apoli
- Page 98 and 99:
96 Chapter | 4 Lipids and Ketones B
- Page 100 and 101:
98 Chapter | 4 Lipids and Ketones
- Page 102 and 103:
100 Chapter | 4 Lipids and Ketones
- Page 104 and 105:
102 Chapter | 4 Lipids and Ketones
- Page 106 and 107:
104 Chapter | 4 Lipids and Ketones
- Page 108 and 109:
106 Chapter | 4 Lipids and Ketones
- Page 110 and 111:
108 Chapter | 4 Lipids and Ketones
- Page 112 and 113:
110 Chapter | 4 Lipids and Ketones
- Page 114 and 115:
112 Chapter | 4 Lipids and Ketones
- Page 116 and 117:
114 Chapter | 4 Lipids and Ketones
- Page 118 and 119:
Chapter 5 Proteins, Proteomics, and
- Page 120 and 121:
III. Metabolism of Proteins 119 C .
- Page 122 and 123:
IV. Plasma Proteins 121 NH 4 HCO
- Page 124 and 125:
V. Methodology 123 molecule. The gl
- Page 126 and 127:
V. Methodology 125 has occurred wil
- Page 128 and 129:
V. Methodology 127 Although attempt
- Page 130 and 131:
V. Methodology 129 kD 94 67 43 2 2
- Page 132 and 133:
V. Methodology 131 D . Specific Pro
- Page 134 and 135:
VI. Normal Plasma and Serum Protein
- Page 136 and 137:
VI. Normal Plasma and Serum Protein
- Page 138 and 139:
VI. Normal Plasma and Serum Protein
- Page 140 and 141:
VI. Normal Plasma and Serum Protein
- Page 142 and 143:
VI. Normal Plasma and Serum Protein
- Page 144 and 145:
VII. Interpretation of Serum Protei
- Page 146 and 147:
VII. Interpretation of Serum Protei
- Page 148 and 149:
VII. Interpretation of Serum Protei
- Page 150 and 151:
References 149 Andersson , M. , Ste
- Page 152 and 153:
References 151 response of haptoglo
- Page 154 and 155:
References 153 dogs with metastasiz
- Page 156 and 157:
References 155 Watson , T. D. G. (
- Page 158:
158 Chapter | 6 Clinical Veterinary
- Page 163 and 164:
V. Methods for Evaluation of the Im
- Page 165 and 166:
V. Methods for Evaluation of the Im
- Page 167 and 168:
V. Methods for Evaluation of the Im
- Page 169:
VI. Laboratory Diagnosis of Disease
- Page 173 and 174:
Chapter 7 The Erythrocyte: Physiolo
- Page 175 and 176:
II. Hematopoiesis 175 progenitor ce
- Page 177 and 178:
III. Developing Erythroid Cells 177
- Page 179 and 180:
III. Developing Erythroid Cells 179
- Page 181 and 182:
III. Developing Erythroid Cells 181
- Page 183 and 184:
III. Developing Erythroid Cells 183
- Page 185 and 186:
IV. Mature RBC 185 immune-mediated
- Page 187 and 188:
IV. Mature RBC 187 TABLE 7-3 Erythr
- Page 189 and 190:
IV. Mature RBC 189 TABLE 7.5 Erythr
- Page 191 and 192:
IV. Mature RBC 191 Echinocyte forma
- Page 193 and 194:
IV. Mature RBC 193 Pig RBC isoantig
- Page 195 and 196:
IV. Mature RBC 195 occurs in chicke
- Page 197 and 198:
IV. Mature RBC 197 inorganic phosph
- Page 199 and 200:
IV. Mature RBC 199 (a) FIGURE 7-6 T
- Page 201 and 202:
IV. Mature RBC 201 RBC 2,3DPG incre
- Page 203 and 204:
IV. Mature RBC 203 mechanisms would
- Page 205 and 206:
IV. Mature RBC 205 released during
- Page 207 and 208:
IV. Mature RBC 207 reduced by ascor
- Page 209 and 210:
V. Determinants of RBC Survival 209
- Page 211 and 212:
V. Determinants of RBC Survival 211
- Page 213 and 214:
VI. Inherited Disorders of RBCs 213
- Page 215 and 216:
VI. Inherited Disorders of RBCs 215
- Page 217 and 218:
VI. Inherited Disorders of RBCs 217
- Page 219 and 220:
described in people. They include a
- Page 221 and 222:
References 221 Boas , F. E. , Forma
- Page 223 and 224:
References 223 Della Rovere , F. ,
- Page 225 and 226:
References 225 Gedde , M. M. , Davi
- Page 227 and 228:
References 227 phosphofructokinase-
- Page 229 and 230:
References 229 Knight , A. P. , Las
- Page 231 and 232:
References 231 Martinovich , D. , a
- Page 233 and 234:
References 233 Pearson , W. , Boerm
- Page 235 and 236:
References 235 Shadduck , R. K. ( 1
- Page 237 and 238:
References 237 Tennant , B. , Dill
- Page 239 and 240:
References 239 Williams , D. M. , L
- Page 241 and 242:
Chapter 8 Porphyrins and the Porphy
- Page 243 and 244:
II. Porphyrins 243 two vinyl groups
- Page 245 and 246:
II. Porphyrins 245 TABLE 8-2 Nomenc
- Page 247 and 248:
IV. Porphyrias 247 6. Uroporphyrins
- Page 249 and 250:
IV. Porphyrias 249 i . Urine It is
- Page 251 and 252:
IV. Porphyrias 251 to localize the
- Page 253 and 254:
IV. Porphyrias 253 FIGURE 8-6 Metab
- Page 255 and 256:
IV. Porphyrias 255 estrogens. The d
- Page 257 and 258:
References 257 and hexachlorobenzen
- Page 259 and 260:
Chapter 9 Iron Metabolism and Its D
- Page 261 and 262:
II. Iron Distribution 261 plasma of
- Page 263 and 264:
IV. Plasma Iron Transport 263 pathw
- Page 265 and 266:
VI. Iron Metabolism in Cells 265 of
- Page 267 and 268:
VI. Iron Metabolism in Cells 267 in
- Page 269 and 270:
VII. Tests for Evaluating Iron Meta
- Page 271 and 272:
VII. Tests for Evaluating Iron Meta
- Page 273 and 274:
VIII. Disorders of Iron Metabolism
- Page 275 and 276:
VIII. Disorders of Iron Metabolism
- Page 277 and 278:
VIII. Disorders of Iron Metabolism
- Page 279 and 280:
References 279 ( Norrdin et al ., 2
- Page 281 and 282:
References 281 Fresco , R. ( 1981 )
- Page 283 and 284:
References 283 Moore , C. V. , Duba
- Page 285 and 286:
References 285 Weiden , P. L. , Hac
- Page 287 and 288:
288 Chapter | 10 Hemostasis TABLE 1
- Page 289 and 290:
290 Chapter | 10 Hemostasis TABLE 1
- Page 291 and 292:
292 Chapter | 10 Hemostasis The pro
- Page 293 and 294:
294 Chapter | 10 Hemostasis exhibit
- Page 295 and 296:
296 Chapter | 10 Hemostasis TABLE 1
- Page 297 and 298:
298 Chapter | 10 Hemostasis that is
- Page 299 and 300:
300 Chapter | 10 Hemostasis TABLE 1
- Page 301 and 302:
302 Chapter | 10 Hemostasis However
- Page 303 and 304:
304 Chapter | 10 Hemostasis 2. Comp
- Page 305 and 306:
306 Chapter | 10 Hemostasis is a re
- Page 307 and 308:
308 Chapter | 10 Hemostasis 2. Asse
- Page 309 and 310:
310 Chapter | 10 Hemostasis necessi
- Page 311 and 312:
312 Chapter | 10 Hemostasis disease
- Page 313 and 314:
314 Chapter | 10 Hemostasis concent
- Page 315 and 316:
316 Chapter | 10 Hemostasis the rol
- Page 317 and 318:
318 Chapter | 10 Hemostasis proport
- Page 319 and 320:
320 Chapter | 10 Hemostasis a consi
- Page 321 and 322:
322 Chapter | 10 Hemostasis Bakhtia
- Page 323 and 324:
324 Chapter | 10 Hemostasis Dowd ,
- Page 325 and 326:
326 Chapter | 10 Hemostasis Kier ,
- Page 327 and 328:
328 Chapter | 10 Hemostasis Nielsen
- Page 329 and 330:
330 Chapter | 10 Hemostasis Tablin
- Page 331 and 332:
332 Chapter | 11 Neutrophil Functio
- Page 333 and 334:
334 Chapter | 11 Neutrophil Functio
- Page 335 and 336:
336 Chapter | 11 Neutrophil Functio
- Page 337 and 338:
338 Chapter | 11 Neutrophil Functio
- Page 339 and 340:
340 Chapter | 11 Neutrophil Functio
- Page 341 and 342:
342 Chapter | 11 Neutrophil Functio
- Page 343 and 344:
344 Chapter | 11 Neutrophil Functio
- Page 345 and 346:
346 Chapter | 11 Neutrophil Functio
- Page 347 and 348:
348 Chapter | 11 Neutrophil Functio
- Page 349 and 350:
350 Chapter | 11 Neutrophil Functio
- Page 351 and 352:
352 Chapter | 12 Diagnostic Enzymol
- Page 353 and 354:
354 Chapter | 12 Diagnostic Enzymol
- Page 355 and 356:
356 Chapter | 12 Diagnostic Enzymol
- Page 357 and 358:
358 Chapter | 12 Diagnostic Enzymol
- Page 359 and 360:
360 Chapter | 12 Diagnostic Enzymol
- Page 361 and 362:
362 Chapter | 12 Diagnostic Enzymol
- Page 363 and 364:
364 Chapter | 12 Diagnostic Enzymol
- Page 365 and 366:
366 Chapter | 12 Diagnostic Enzymol
- Page 367 and 368:
368 Chapter | 12 Diagnostic Enzymol
- Page 369 and 370:
370 Chapter | 12 Diagnostic Enzymol
- Page 371 and 372:
372 Chapter | 12 Diagnostic Enzymol
- Page 373 and 374:
374 Chapter | 12 Diagnostic Enzymol
- Page 375 and 376:
376 Chapter | 12 Diagnostic Enzymol
- Page 377 and 378:
378 Chapter | 12 Diagnostic Enzymol
- Page 379 and 380:
380 Chapter | 13 Hepatic Function L
- Page 381 and 382:
382 Chapter | 13 Hepatic Function e
- Page 383 and 384:
384 Chapter | 13 Hepatic Function p
- Page 385 and 386:
386 Chapter | 13 Hepatic Function m
- Page 387 and 388:
388 Chapter | 13 Hepatic Function s
- Page 389 and 390:
390 Chapter | 13 Hepatic Function f
- Page 391 and 392:
392 Chapter | 13 Hepatic Function T
- Page 393 and 394:
394 Chapter | 13 Hepatic Function 2
- Page 395 and 396:
396 Chapter | 13 Hepatic Function u
- Page 397 and 398:
398 Chapter | 13 Hepatic Function 2
- Page 399 and 400:
400 Chapter | 13 Hepatic Function c
- Page 401 and 402:
402 Chapter | 13 Hepatic Function F
- Page 403 and 404:
404 Chapter | 13 Hepatic Function A
- Page 405 and 406:
406 Chapter | 13 Hepatic Function E
- Page 407 and 408:
408 Chapter | 13 Hepatic Function K
- Page 409 and 410:
410 Chapter | 13 Hepatic Function R
- Page 411 and 412:
412 Chapter | 13 Hepatic Function W
- Page 413 and 414:
414 Chapter | 14 Gastrointestinal F
- Page 415 and 416:
416 Chapter | 14 Gastrointestinal F
- Page 417 and 418:
418 Chapter | 14 Gastrointestinal F
- Page 419 and 420:
420 Chapter | 14 Gastrointestinal F
- Page 421 and 422:
422 Chapter | 14 Gastrointestinal F
- Page 423 and 424:
424 Chapter | 14 Gastrointestinal F
- Page 425 and 426:
426 Chapter | 14 Gastrointestinal F
- Page 427 and 428:
428 Chapter | 14 Gastrointestinal F
- Page 429 and 430:
430 Chapter | 14 Gastrointestinal F
- Page 431 and 432:
432 Chapter | 14 Gastrointestinal F
- Page 433 and 434:
434 Chapter | 14 Gastrointestinal F
- Page 435 and 436:
436 Chapter | 14 Gastrointestinal F
- Page 437 and 438:
438 Chapter | 14 Gastrointestinal F
- Page 439 and 440:
440 Chapter | 14 Gastrointestinal F
- Page 441 and 442:
442 Chapter | 14 Gastrointestinal F
- Page 443 and 444:
444 Chapter | 14 Gastrointestinal F
- Page 445 and 446:
446 Chapter | 14 Gastrointestinal F
- Page 447 and 448:
448 Chapter | 14 Gastrointestinal F
- Page 449 and 450:
450 Chapter | 14 Gastrointestinal F
- Page 451 and 452:
452 Chapter | 14 Gastrointestinal F
- Page 453 and 454:
454 Chapter | 14 Gastrointestinal F
- Page 455 and 456:
456 Chapter | 14 Gastrointestinal F
- Page 457 and 458:
Chapter 15 Skeletal Muscle Function
- Page 459 and 460:
II. Specialization of the Sarcolemm
- Page 461 and 462:
II. Specialization of the Sarcolemm
- Page 463 and 464:
III. Heterogeneity of Skeletal Musc
- Page 465 and 466:
III. Heterogeneity of Skeletal Musc
- Page 467 and 468: V. Exercise and Adaptations to Trai
- Page 469 and 470: VI. Diagnostic Laboratory Methods f
- Page 471 and 472: VI. Diagnostic Laboratory Methods f
- Page 473 and 474: IX. Selected Neuromuscular Disorder
- Page 475 and 476: IX. Selected Neuromuscular Disorder
- Page 477 and 478: References 479 and, recently, there
- Page 479 and 480: References 481 Engel , A. G. ( 2004
- Page 481 and 482: References 483 Paciello , O. , Maio
- Page 483 and 484: Chapter 16 Kidney Function and Dama
- Page 485 and 486: II. Kidney Morphology and Function
- Page 487 and 488: II. Kidney Morphology and Function
- Page 489 and 490: III. Tests of Kidney Function 491 (
- Page 491 and 492: III. Tests of Kidney Function 493 T
- Page 493 and 494: III. Tests of Kidney Function 495 B
- Page 495 and 496: 6 5 4 3 2 1 0 Dog Cat Equine Cattle
- Page 497 and 498: III. Tests of Kidney Function 499 d
- Page 499 and 500: IV. Tests of Kidney Damage 501 1000
- Page 501 and 502: IV. Tests of Kidney Damage 503 and
- Page 503 and 504: IV. Tests of Kidney Damage 505 Enzy
- Page 505 and 506: V. Biochemical Changes in Kidney Di
- Page 507 and 508: V. Biochemical Changes in Kidney Di
- Page 509 and 510: References 511 were reported to occ
- Page 511 and 512: References 513 Bovee , K. C. ( 1969
- Page 513 and 514: References 515 Deguchi , E. , and A
- Page 515 and 516: References 517 Fleming , S. A. , Hu
- Page 517: References 519 Harvey , D. G. ( 197
- Page 521 and 522: References 523 creatinine measureme
- Page 523 and 524: References 525 Reusch , C. , Vochez
- Page 525 and 526: References 527 Terry , R. , Hawkins
- Page 527 and 528: Chapter 17 Fluid, Electrolyte, and
- Page 530 and 531: 532 Chapter | 17 Fluid, Electrolyte
- Page 534 and 535: 536 Chapter | 17 Fluid, Electrolyte
- Page 536 and 537: 538 Chapter | 17 Fluid, Electrolyte
- Page 538 and 539: 540 Chapter | 17 Fluid, Electrolyte
- Page 540 and 541: 542 Chapter | 17 Fluid, Electrolyte
- Page 542 and 543: 544 Chapter | 17 Fluid, Electrolyte
- Page 544 and 545: 546 Chapter | 17 Fluid, Electrolyte
- Page 546 and 547: 548 Chapter | 17 Fluid, Electrolyte
- Page 548 and 549: 550 Chapter | 17 Fluid, Electrolyte
- Page 551 and 552: VIII. Clinicopathological Indicator
- Page 553 and 554: References 555 plasma water, electr
- Page 555 and 556: References 557 Krzywanek , H. ( 197
- Page 557 and 558: References 559 Strombeck , D. R. (1
- Page 559 and 560: 562 Chapter | 18 Pituitary Function
- Page 561 and 562: 564 Chapter | 18 Pituitary Function
- Page 563 and 564: 566 Chapter | 18 Pituitary Function
- Page 565 and 566: 568 Chapter | 18 Pituitary Function
- Page 567 and 568: 570 Chapter | 18 Pituitary Function
- Page 569 and 570:
572 Chapter | 18 Pituitary Function
- Page 571 and 572:
574 Chapter | 18 Pituitary Function
- Page 573 and 574:
576 Chapter | 18 Pituitary Function
- Page 575 and 576:
578 Chapter | 18 Pituitary Function
- Page 577 and 578:
580 Chapter | 18 Pituitary Function
- Page 579 and 580:
582 Chapter | 18 Pituitary Function
- Page 581 and 582:
584 Chapter | 18 Pituitary Function
- Page 583 and 584:
586 Chapter | 18 Pituitary Function
- Page 585 and 586:
588 Chapter | 18 Pituitary Function
- Page 587 and 588:
590 Chapter | 18 Pituitary Function
- Page 589 and 590:
592 Chapter | 18 Pituitary Function
- Page 591 and 592:
594 Chapter | 18 Pituitary Function
- Page 593 and 594:
596 Chapter | 18 Pituitary Function
- Page 595 and 596:
598 Chapter | 18 Pituitary Function
- Page 597 and 598:
600 Chapter | 18 Pituitary Function
- Page 599 and 600:
602 Chapter | 18 Pituitary Function
- Page 601 and 602:
604 Chapter | 18 Pituitary Function
- Page 603 and 604:
606 Chapter | 19 Adrenocortical Fun
- Page 605 and 606:
608 Chapter | 19 Adrenocortical Fun
- Page 607 and 608:
610 Chapter | 19 Adrenocortical Fun
- Page 609 and 610:
612 Chapter | 19 Adrenocortical Fun
- Page 611 and 612:
614 Chapter | 19 Adrenocortical Fun
- Page 613 and 614:
616 Chapter | 19 Adrenocortical Fun
- Page 615 and 616:
618 Chapter | 19 Adrenocortical Fun
- Page 617 and 618:
620 Chapter | 19 Adrenocortical Fun
- Page 619 and 620:
622 Chapter | 19 Adrenocortical Fun
- Page 621 and 622:
624 Chapter | 20 Thyroid Function a
- Page 623 and 624:
626 Chapter | 20 Thyroid Function t
- Page 625 and 626:
628 Chapter | 20 Thyroid Function A
- Page 627 and 628:
630 Chapter | 20 Thyroid Function S
- Page 629 and 630:
632 Chapter | 20 Thyroid Function a
- Page 631 and 632:
634 Chapter | 20 Thyroid Function O
- Page 633 and 634:
636 Chapter | 21 Clinical Reproduct
- Page 635 and 636:
638 Chapter | 21 Clinical Reproduct
- Page 637 and 638:
640 Chapter | 21 Clinical Reproduct
- Page 639 and 640:
642 Chapter | 21 Clinical Reproduct
- Page 641 and 642:
644 Chapter | 21 Clinical Reproduct
- Page 643 and 644:
646 Chapter | 21 Clinical Reproduct
- Page 645 and 646:
648 Chapter | 21 Clinical Reproduct
- Page 647 and 648:
650 Chapter | 21 Clinical Reproduct
- Page 649 and 650:
652 Chapter | 21 Clinical Reproduct
- Page 651 and 652:
654 Chapter | 21 Clinical Reproduct
- Page 653 and 654:
656 Chapter | 21 Clinical Reproduct
- Page 655 and 656:
658 Chapter | 21 Clinical Reproduct
- Page 657 and 658:
660 Chapter | 21 Clinical Reproduct
- Page 659 and 660:
662 Chapter | 21 Clinical Reproduct
- Page 661 and 662:
664 Chapter | 22 Trace Minerals the
- Page 663 and 664:
666 Chapter | 22 Trace Minerals the
- Page 665 and 666:
668 Chapter | 22 Trace Minerals P i
- Page 667 and 668:
670 Chapter | 22 Trace Minerals be
- Page 669 and 670:
Copper Cuproreductase Cytochromes C
- Page 671 and 672:
674 Chapter | 22 Trace Minerals 2 .
- Page 673 and 674:
676 Chapter | 22 Trace Minerals Cor
- Page 675 and 676:
678 Chapter | 22 Trace Minerals inf
- Page 677 and 678:
680 Chapter | 22 Trace Minerals tis
- Page 679 and 680:
682 Chapter | 22 Trace Minerals VI
- Page 681 and 682:
684 Chapter | 22 Trace Minerals red
- Page 683 and 684:
686 Chapter | 22 Trace Minerals of
- Page 685 and 686:
688 Chapter | 22 Trace Minerals Per
- Page 687 and 688:
690 Chapter | 22 Trace Minerals In
- Page 689 and 690:
692 Chapter | 22 Trace Minerals Liu
- Page 691 and 692:
Chapter 23 Vitamins Robert B. Rucke
- Page 693 and 694:
III. Fat-Soluble Vitamins 697 TABLE
- Page 695 and 696:
III. Fat-Soluble Vitamins 699 Carot
- Page 697 and 698:
III. Fat-Soluble Vitamins 701 Major
- Page 699 and 700:
III. Fat-Soluble Vitamins 703 doses
- Page 701 and 702:
III. Fat-Soluble Vitamins 705 Diet
- Page 703 and 704:
III. Fat-Soluble Vitamins 707 conta
- Page 705 and 706:
III. Fat-Soluble Vitamins 709 immun
- Page 707 and 708:
IV. Water-Soluble Vitamins 711 are
- Page 709 and 710:
IV. Water-Soluble Vitamins 713 abil
- Page 711 and 712:
IV. Water-Soluble Vitamins 715 5’
- Page 713 and 714:
IV. Water-Soluble Vitamins 717 H 2
- Page 715 and 716:
IV. Water-Soluble Vitamins 719 Enzy
- Page 718 and 719:
722 Chapter | 23 Vitamins When biot
- Page 720 and 721:
724 Chapter | 23 Vitamins Cyanocoba
- Page 722 and 723:
726 Chapter | 23 Vitamins V . VITAM
- Page 724 and 725:
728 Chapter | 23 Vitamins nature, r
- Page 726 and 727:
730 Chapter | 23 Vitamins Stites ,
- Page 728 and 729:
732 Chapter | 24 Lysosomal Storage
- Page 730 and 731:
734 Chapter | 24 Lysosomal Storage
- Page 732 and 733:
736 Chapter | 24 Lysosomal Storage
- Page 734 and 735:
738 Chapter | 24 Lysosomal Storage
- Page 736 and 737:
740 Chapter | 24 Lysosomal Storage
- Page 738 and 739:
742 Chapter | 24 Lysosomal Storage
- Page 740 and 741:
744 Chapter | 24 Lysosomal Storage
- Page 742 and 743:
746 Chapter | 24 Lysosomal Storage
- Page 744 and 745:
748 Chapter | 24 Lysosomal Storage
- Page 746 and 747:
Chapter 25 Tumor Markers Michael D.
- Page 748 and 749:
II. Serum Tumor Markers 753 also be
- Page 750 and 751:
III. Flow Cytometry 755 cancer of t
- Page 752 and 753:
V. Immunohistochemistry/Immunocytoc
- Page 754 and 755:
V. Immunohistochemistry/Immunocytoc
- Page 756 and 757:
References 761 analysis will facili
- Page 758 and 759:
References 763 Fernandez , N. J. ,
- Page 760 and 761:
References 765 Meinecke , B. , and
- Page 762 and 763:
References 767 Walter , J. ( 2000 )
- Page 764 and 765:
770 Chapter | 26 Cerebrospinal Flui
- Page 766 and 767:
772 Chapter | 26 Cerebrospinal Flui
- Page 768 and 769:
774 Chapter | 26 Cerebrospinal Flui
- Page 770 and 771:
776 Chapter | 26 Cerebrospinal Flui
- Page 772 and 773:
778 Chapter | 26 Cerebrospinal Flui
- Page 774 and 775:
TABLE 26-7 Continued Constituent Ro
- Page 776 and 777:
782 Chapter | 26 Cerebrospinal Flui
- Page 778 and 779:
784 Chapter | 26 Cerebrospinal Flui
- Page 780 and 781:
786 Chapter | 26 Cerebrospinal Flui
- Page 782 and 783:
788 Chapter | 26 Cerebrospinal Flui
- Page 784 and 785:
790 Chapter | 26 Cerebrospinal Flui
- Page 786 and 787:
792 Chapter | 26 Cerebrospinal Flui
- Page 788 and 789:
794 Chapter | 26 Cerebrospinal Flui
- Page 790 and 791:
796 Chapter | 26 Cerebrospinal Flui
- Page 792 and 793:
798 Chapter | 26 Cerebrospinal Flui
- Page 794 and 795:
800 Chapter | 26 Cerebrospinal Flui
- Page 796 and 797:
802 Chapter | 26 Cerebrospinal Flui
- Page 798 and 799:
804 Chapter | 26 Cerebrospinal Flui
- Page 800 and 801:
806 Chapter | 26 Cerebrospinal Flui
- Page 802 and 803:
808 Chapter | 26 Cerebrospinal Flui
- Page 804 and 805:
810 Chapter | 26 Cerebrospinal Flui
- Page 806 and 807:
812 Chapter | 26 Cerebrospinal Flui
- Page 808 and 809:
814 Chapter | 26 Cerebrospinal Flui
- Page 810 and 811:
816 Chapter | 26 Cerebrospinal Flui
- Page 812 and 813:
818 Chapter | 26 Cerebrospinal Flui
- Page 814 and 815:
Chapter 27 Clinical Biochemistry in
- Page 816 and 817:
II. Hepatotoxicity 823 Therefore, A
- Page 818 and 819:
III. Nephrotoxicity 825 suggested a
- Page 820 and 821:
IV. Toxins Affecting Skeletal and C
- Page 822 and 823:
VII. Toxins Affecting Erythrocytes
- Page 824 and 825:
VIII. Toxins Affecting Hemoglobin a
- Page 826 and 827:
IX. Toxins Affecting the Nervous Sy
- Page 828 and 829:
References 835 Plants classified as
- Page 830 and 831:
References 837 Solaiman , S. G. , M
- Page 832 and 833:
840 Chapter | 28 Avian Clinical Bio
- Page 834 and 835:
842 Chapter | 28 Avian Clinical Bio
- Page 836 and 837:
844 Chapter | 28 Avian Clinical Bio
- Page 838 and 839:
846 Chapter | 28 Avian Clinical Bio
- Page 840 and 841:
848 Chapter | 28 Avian Clinical Bio
- Page 842 and 843:
850 Chapter | 28 Avian Clinical Bio
- Page 844 and 845:
Budgerigar ALAT (IU/g tissue) Budge
- Page 846 and 847:
854 Chapter | 28 Avian Clinical Bio
- Page 848 and 849:
856 Chapter | 28 Avian Clinical Bio
- Page 850 and 851:
858 Chapter | 28 Avian Clinical Bio
- Page 852 and 853:
860 Chapter | 28 Avian Clinical Bio
- Page 854 and 855:
862 Chapter | 28 Avian Clinical Bio
- Page 856 and 857:
864 Chapter | 28 Avian Clinical Bio
- Page 858 and 859:
866 Chapter | 28 Avian Clinical Bio
- Page 860 and 861:
868 Chapter | 28 Avian Clinical Bio
- Page 862 and 863:
870 Chapter | 28 Avian Clinical Bio
- Page 864 and 865:
872 Chapter | 28 Avian Clinical Bio
- Page 866 and 867:
874 Appendix | I SI Units TABLE E S
- Page 868 and 869:
Appendix II Conversion Factors of S
- Page 870 and 871:
Appendix IV Stability of Serum Enzy
- Page 872 and 873:
Appendix VI Nomogram for Computing
- Page 874 and 875:
t0100 Appendix VIII Blood Analyte R
- Page 876 and 877:
884 Appendix | VIII Blood Analyte R
- Page 878 and 879:
886 Appendix | VIII Blood Analyte R
- Page 880 and 881:
888 Appendix | VIII Blood Analyte R
- Page 882 and 883:
890 Appendix | IX Blood Analyte Ref
- Page 884 and 885:
892 Appendix | IX Blood Analyte Ref
- Page 886 and 887:
894 Appendix | IX Blood Analyte Ref
- Page 888 and 889:
Appendix X Blood Analyte Reference
- Page 890 and 891:
Appendix XI Blood Analyte Reference
- Page 892 and 893:
Appendix XII Urine Analyte Referenc
- Page 894 and 895:
902 Appendix | XIII Cerebrospinal F
- Page 896:
904 Appendix | XIV Cerebrospinal Fl